NCT00237575View on ClinicalTrials.gov

Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer

PHASE3TerminatedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Bladder Cancer
Interventions
DRUG

gemcitabine

DRUG

cisplatin

DRUG

sargramostim

DRUG

filgrastim

Trial Locations (4)

10467

Montefiore Medical Center, The Bronx

10532

New York Medical College, Hawthorne

40202

University of Louisville, Louisville

68198-7680

University of Nebraska, Omaha

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

University of Kentucky

OTHER

NCT00237575 - Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer | Biotech Hunter | Biotech Hunter